Patenting and Pricing Eliquis, Ozempic, and Other Medicare-Targeted Drugs

Second Request ›

1:02:07 | Jul 29th

Teddy Downey, Executive Editor of The Capitol Forum, sits down with Tahir Amin, co-founder of I-MAK, to discuss the pharmaceutical industry’s misuse of the U.S. patent system—and what it costs America...Show More